Skip to main content
Erschienen in: Clinical Pharmacokinetics 2/2000

01.02.2000 | Leading Article

Drugs in Nails

Physiology, Pharmacokinetics and Forensic Toxicology

verfasst von: Alessandro Palmeri, Simona Pichini, Roberta Pacifici, Dr Piergiorgio Zuccaro, Annunziata Lopez

Erschienen in: Clinical Pharmacokinetics | Ausgabe 2/2000

Einloggen, um Zugang zu erhalten

Abstract

In recent years, drug analysis in keratinised matrices, such as hair and nails, has received considerable attention because of several advantages over drug testing methodologies employing body fluids, such as urine or serum. For example, keratinic matrices, such as finger- and toenails, can accumulate drugs during long term exposure. Drugs are incorporated into nails by a double mechanism: (i) deposition into the root of the growing nail via the blood flow in the nail matrix; and (ii) incorporation via the nail bed during growth from the lunula to the beginning of the free margin. Together, these account for a wide retrospective window of drug detection.
Nails can provide a good forensic matrix for the detection of drugs of abuse. Indeed, the international literature has reported the use of nail analysis in postmortem detection of drugs of abuse, drug testing in the workplace and drug screening to detect prenatal exposure, even though further studies are needed for correct interpretation of the data obtained.
Another application of drug analysis in nails consists of the possibility of detecting the presence of an antimycotic at the site of action during antifungal therapy for patients with onychomycosis. When available, this evidence has permitted drug treatment of a shorter duration and reduced toxicity However, so far the potential of drug monitoring in nails still lacks harmonisation and validation of analytical methodologies and a better comprehension of the possible correlation between drug concentrations in the matrix and period of exposure.
Literatur
1.
Zurück zum Zitat Cone EJ, Welch MJ. Introduction and overview: National Institute on Drug Abuse special publication on hair analysis for drug of abuse. In: Cone EJ, Welch MJ, Grigson Babeki MB, editors. Hair testing for drugs of abuse: international research on standards and technology [NIH Publication No. 95-3727]. Bethesda (MD): National Institute on Drug Abuse, 1995: 1–6. Cone EJ, Welch MJ. Introduction and overview: National Institute on Drug Abuse special publication on hair analysis for drug of abuse. In: Cone EJ, Welch MJ, Grigson Babeki MB, editors. Hair testing for drugs of abuse: international research on standards and technology [NIH Publication No. 95-3727]. Bethesda (MD): National Institute on Drug Abuse, 1995: 1–6.
2.
Zurück zum Zitat Pichini S, Altieri I, Zuccaro P, et al. Drug monitoring in non-conventional biological fluids and matrices. Clin Phar-macokinet 1996; 30 (3): 211–28.CrossRef Pichini S, Altieri I, Zuccaro P, et al. Drug monitoring in non-conventional biological fluids and matrices. Clin Phar-macokinet 1996; 30 (3): 211–28.CrossRef
3.
Zurück zum Zitat Miyazawa N, Uematsu T. Analysis of ofloxacin in hair as a measure of hair growth and a time marker for hair analysis. Ther Drug Monit 1992; 14: 525–8.PubMedCrossRef Miyazawa N, Uematsu T. Analysis of ofloxacin in hair as a measure of hair growth and a time marker for hair analysis. Ther Drug Monit 1992; 14: 525–8.PubMedCrossRef
4.
Zurück zum Zitat Uematsu T, Kondo K, Yano S, et al. Measurement of tem-afloxacin in human scalp hair as an index of drug exposure. J Pharm Sci 1994; 83: 42–5.PubMedCrossRef Uematsu T, Kondo K, Yano S, et al. Measurement of tem-afloxacin in human scalp hair as an index of drug exposure. J Pharm Sci 1994; 83: 42–5.PubMedCrossRef
5.
Zurück zum Zitat Uematsu T, Sato R, Suzuki K, et al. Human scalp hair as evidence of individual dosage history of haloperidol: method and retrospective study. Eur J Clin Pharmacol 1989; 37: 239–44.PubMedCrossRef Uematsu T, Sato R, Suzuki K, et al. Human scalp hair as evidence of individual dosage history of haloperidol: method and retrospective study. Eur J Clin Pharmacol 1989; 37: 239–44.PubMedCrossRef
6.
Zurück zum Zitat Matsuno H, Uematsu T, Nakashima M. The measurement of haloperidol and reduced haloperidol in hair as an index of dosage history. Br J Clin Pharmacol 1990; 29: 187–94.PubMedCrossRef Matsuno H, Uematsu T, Nakashima M. The measurement of haloperidol and reduced haloperidol in hair as an index of dosage history. Br J Clin Pharmacol 1990; 29: 187–94.PubMedCrossRef
7.
Zurück zum Zitat Williams J, Patsalos PN, Wilson JF. Hair analysis as a potential index of therapeutic compliance in the treatment of epilepsy. Forensic Sci Int 1997; 84: 113–22.PubMedCrossRef Williams J, Patsalos PN, Wilson JF. Hair analysis as a potential index of therapeutic compliance in the treatment of epilepsy. Forensic Sci Int 1997; 84: 113–22.PubMedCrossRef
8.
Zurück zum Zitat Cone EJ, Welch MJ, Grigson Babeki MB, editors. Hair testing for drugs of abuse: international research on standards and technology [NIH Publication No. 95-3727]. Bethesda (MD): National Institute on Drug Abuse, 1995. Cone EJ, Welch MJ, Grigson Babeki MB, editors. Hair testing for drugs of abuse: international research on standards and technology [NIH Publication No. 95-3727]. Bethesda (MD): National Institute on Drug Abuse, 1995.
9.
Zurück zum Zitat Haley NJ, Hoffmann D. Analysis for nicotine and cotinine in hair to determine cigarette smoker status. Clin Chem 1985; 31: 1598–600.PubMed Haley NJ, Hoffmann D. Analysis for nicotine and cotinine in hair to determine cigarette smoker status. Clin Chem 1985; 31: 1598–600.PubMed
10.
Zurück zum Zitat Pichini S, Pacifici R, Altieri I, et al. Analysis of nicotine and cotinine in human hair by high-performance liquid chromatography and comparative determination by radioimmunoassay. In: Cone EJ, Welch MJ, Grigson Babeki MB, editors. Hair testing for drugs of abuse: international research on standards and technology [NTH Publication No. 95-3727]. Bethesda (MD): National Institute on Drug Abuse, 1995: 212–24. Pichini S, Pacifici R, Altieri I, et al. Analysis of nicotine and cotinine in human hair by high-performance liquid chromatography and comparative determination by radioimmunoassay. In: Cone EJ, Welch MJ, Grigson Babeki MB, editors. Hair testing for drugs of abuse: international research on standards and technology [NTH Publication No. 95-3727]. Bethesda (MD): National Institute on Drug Abuse, 1995: 212–24.
11.
Zurück zum Zitat Pepin G, Gaillard Y. Concordance between self-reported drug use and findings in hair about cocaine and heroin. Forensic Sci Int 1997; 84: 37–41.PubMedCrossRef Pepin G, Gaillard Y. Concordance between self-reported drug use and findings in hair about cocaine and heroin. Forensic Sci Int 1997; 84: 37–41.PubMedCrossRef
12.
Zurück zum Zitat Klein J, Forman R, Eliopoulos C, et al. A method for simultaneous measurement of cocaine and nicotine in neonatal hair. Ther Drug Monit 1994; 16: 67–70.PubMedCrossRef Klein J, Forman R, Eliopoulos C, et al. A method for simultaneous measurement of cocaine and nicotine in neonatal hair. Ther Drug Monit 1994; 16: 67–70.PubMedCrossRef
13.
Zurück zum Zitat Pounds A, Pearson EF, Turner TD. Arsenic in fingernails. J Forensic Sci Soc 1979; 19: 165–73.PubMedCrossRef Pounds A, Pearson EF, Turner TD. Arsenic in fingernails. J Forensic Sci Soc 1979; 19: 165–73.PubMedCrossRef
14.
Zurück zum Zitat Lander H, Hodge PR, Crisp CS. Arsenic in hair and nails: its significance in acute arsenical poisoning. J Forensic Med 1965; 12: 52–67.PubMed Lander H, Hodge PR, Crisp CS. Arsenic in hair and nails: its significance in acute arsenical poisoning. J Forensic Med 1965; 12: 52–67.PubMed
15.
Zurück zum Zitat Shapiro HA. Arsenic content of human hair and nails: its interpretation. J Forensic Med 1967; 14: 65–71.PubMed Shapiro HA. Arsenic content of human hair and nails: its interpretation. J Forensic Med 1967; 14: 65–71.PubMed
16.
Zurück zum Zitat Pirl JN, Townsend GF, Valaitis AK, et al. Death by arsenic: a comparative evaluation of exhumed body tissues in the presence of external contamination. J Anal Toxicol 1983; 7: 216–9.PubMed Pirl JN, Townsend GF, Valaitis AK, et al. Death by arsenic: a comparative evaluation of exhumed body tissues in the presence of external contamination. J Anal Toxicol 1983; 7: 216–9.PubMed
17.
Zurück zum Zitat Gerhardsson L, Englyst V, Lundstrom NG, et al. Lead in tissues of deceased lead smelter workers. J Trace Elem Med Biol 1995; 9: 136–43.PubMedCrossRef Gerhardsson L, Englyst V, Lundstrom NG, et al. Lead in tissues of deceased lead smelter workers. J Trace Elem Med Biol 1995; 9: 136–43.PubMedCrossRef
18.
Zurück zum Zitat Gerhardsson L, Brune D, Lundstrom NG, et al. Biological specimen bank for smelter workers. Sci Total Environ 1993; 139–140: 157–73.PubMedCrossRef Gerhardsson L, Brune D, Lundstrom NG, et al. Biological specimen bank for smelter workers. Sci Total Environ 1993; 139–140: 157–73.PubMedCrossRef
19.
Zurück zum Zitat Wilhelm M, Hafner D, Lombeck I, et al. Monitoring of cadmium, copper, lead and zinc status in young children using toenails: comparison with scalp hair. Sci Total Environ 1991; 103: 199–207.PubMedCrossRef Wilhelm M, Hafner D, Lombeck I, et al. Monitoring of cadmium, copper, lead and zinc status in young children using toenails: comparison with scalp hair. Sci Total Environ 1991; 103: 199–207.PubMedCrossRef
20.
Zurück zum Zitat Alexiou D, Koutselinis A, Manolidis C, et al. The content of trace elements (Cu, Zn, Fe, Mg) in fingernails of children. Dermatologica 1980; 160: 380–2.PubMedCrossRef Alexiou D, Koutselinis A, Manolidis C, et al. The content of trace elements (Cu, Zn, Fe, Mg) in fingernails of children. Dermatologica 1980; 160: 380–2.PubMedCrossRef
21.
Zurück zum Zitat Kasperek K, Iyengar GV, Feinendegen LE, et al. Multielement analysis of fingernail, scalp hair and water samples from Egypt (a preliminary study). Sci Total Environ 1982; 22: 149–68.PubMedCrossRef Kasperek K, Iyengar GV, Feinendegen LE, et al. Multielement analysis of fingernail, scalp hair and water samples from Egypt (a preliminary study). Sci Total Environ 1982; 22: 149–68.PubMedCrossRef
22.
Zurück zum Zitat Schäfer-Körting M. Pharmacokinetic optimisation of oral antifungal therapy. Clin Pharmacokinet 1993; 25: 329–41.PubMedCrossRef Schäfer-Körting M. Pharmacokinetic optimisation of oral antifungal therapy. Clin Pharmacokinet 1993; 25: 329–41.PubMedCrossRef
23.
Zurück zum Zitat Suzuki O, Hattori H, Asano M. Nails as useful materials for detection of methamphetamine or amphetamine abuse. Forensic Sci Int 1984; 24: 9–16.PubMedCrossRef Suzuki O, Hattori H, Asano M. Nails as useful materials for detection of methamphetamine or amphetamine abuse. Forensic Sci Int 1984; 24: 9–16.PubMedCrossRef
24.
Zurück zum Zitat Walters KA, Flynn GL. Permeability characteristics of the human nail plate. Int J Cosmet Sci 1983; 5: 231–46.PubMedCrossRef Walters KA, Flynn GL. Permeability characteristics of the human nail plate. Int J Cosmet Sci 1983; 5: 231–46.PubMedCrossRef
25.
Zurück zum Zitat Le Gros Clark WE, Dudley Buxton LH. Studies in nail growth. Br J Dermatol 1938; 50: 221–35.CrossRef Le Gros Clark WE, Dudley Buxton LH. Studies in nail growth. Br J Dermatol 1938; 50: 221–35.CrossRef
26.
Zurück zum Zitat Bean WB. Anote on fingernail growth. J Invest Dermatol 1953; 20: 27–31.PubMed Bean WB. Anote on fingernail growth. J Invest Dermatol 1953; 20: 27–31.PubMed
27.
Zurück zum Zitat Johnson M, Shuster S. Ventral nail contribution to the nail plate is continuous along the length of the nail bed [abstract]. Br J Dermatol 1990; 123: 825. Johnson M, Shuster S. Ventral nail contribution to the nail plate is continuous along the length of the nail bed [abstract]. Br J Dermatol 1990; 123: 825.
28.
Zurück zum Zitat Zaias N. The movement of the nail bed. J Invest Dermatol 1967; 48: 402–3.PubMed Zaias N. The movement of the nail bed. J Invest Dermatol 1967; 48: 402–3.PubMed
29.
Zurück zum Zitat Norton LA. Incorporation of thymidine-methyl-H3 and glycine-2-H3 in the nail matrix and bed of humans. J Invest Dermatol 1971; 56: 61–8.PubMedCrossRef Norton LA. Incorporation of thymidine-methyl-H3 and glycine-2-H3 in the nail matrix and bed of humans. J Invest Dermatol 1971; 56: 61–8.PubMedCrossRef
30.
Zurück zum Zitat Johnson M, Comaish JS, Shuster S. Nail is produced by the normal nail bed: a controversy resolved. Br J Dermatol 1991; 125: 27–9.PubMedCrossRef Johnson M, Comaish JS, Shuster S. Nail is produced by the normal nail bed: a controversy resolved. Br J Dermatol 1991; 125: 27–9.PubMedCrossRef
31.
Zurück zum Zitat Johnson M, Shuster S. Continuous formation of nail along the bed. Br J Dermatol 1993; 128: 277–80.PubMedCrossRef Johnson M, Shuster S. Continuous formation of nail along the bed. Br J Dermatol 1993; 128: 277–80.PubMedCrossRef
32.
Zurück zum Zitat Shuster S, Munro CS. Single dose treatment of fungal nail disease [letter]. Lancet 1992; 339: 1066.PubMedCrossRef Shuster S, Munro CS. Single dose treatment of fungal nail disease [letter]. Lancet 1992; 339: 1066.PubMedCrossRef
33.
Zurück zum Zitat Lemos NP, Anderson RA, Robertson JR. Nail analysis for drug of abuse: extraction and determination of cannabis in fingernails by RIA and GC-MS. J Anal Toxicol 1999; 23: 147–52.PubMed Lemos NP, Anderson RA, Robertson JR. Nail analysis for drug of abuse: extraction and determination of cannabis in fingernails by RIA and GC-MS. J Anal Toxicol 1999; 23: 147–52.PubMed
34.
Zurück zum Zitat Kidwell DA, Blank DL. Mechanisms of incorporation of drugs into hair and the interpretation of hair analysis data. In: Cone EJ, Welch MJ, Grigson Babeki MB, editors. Hair testing for drugs of abuse: international research on standards and technology [NIH Publication No. 95-3727]. Bethesda (MD): National Institute on Drug Abuse, 1995: 19–90. Kidwell DA, Blank DL. Mechanisms of incorporation of drugs into hair and the interpretation of hair analysis data. In: Cone EJ, Welch MJ, Grigson Babeki MB, editors. Hair testing for drugs of abuse: international research on standards and technology [NIH Publication No. 95-3727]. Bethesda (MD): National Institute on Drug Abuse, 1995: 19–90.
35.
Zurück zum Zitat Pötsch L, Skopp G, Moeller MR. Biochemical approach on the conservation of drug molecules during hair fibres formation. Forensic Sci Int 1997; 84: 25–35.PubMedCrossRef Pötsch L, Skopp G, Moeller MR. Biochemical approach on the conservation of drug molecules during hair fibres formation. Forensic Sci Int 1997; 84: 25–35.PubMedCrossRef
36.
Zurück zum Zitat Nakahara Y, Takahashi K, Kikura R. Hair analysis for drug of abuse. X. Effect of physicochemical properties of drug on the incorporation rates into hair. Biol Pharm Bull 1995; 18: 1223–7. Nakahara Y, Takahashi K, Kikura R. Hair analysis for drug of abuse. X. Effect of physicochemical properties of drug on the incorporation rates into hair. Biol Pharm Bull 1995; 18: 1223–7.
37.
Zurück zum Zitat Munro CS, Rees JL, Shuster S. The unexpectedly rapid response of fungal nail infection to short duration therapy. Acta Derm Venereol 1992; 72: 131–3.PubMed Munro CS, Rees JL, Shuster S. The unexpectedly rapid response of fungal nail infection to short duration therapy. Acta Derm Venereol 1992; 72: 131–3.PubMed
38.
Zurück zum Zitat Matthieu L, De Doncker P, Cauwenbergh G, et al. Itraconazole penetrates the nail via the nail matrix and the nail bed: an investigation in onychomycosis. Clin Exp Dermatol 1991; 16: 374–6.PubMedCrossRef Matthieu L, De Doncker P, Cauwenbergh G, et al. Itraconazole penetrates the nail via the nail matrix and the nail bed: an investigation in onychomycosis. Clin Exp Dermatol 1991; 16: 374–6.PubMedCrossRef
39.
Zurück zum Zitat Willemsen M, De Doncker P, Willems J, et al. Posttreatment itraconazole levels in the nail. J Am Acad Dermatol 1992; 26: 731–5.PubMedCrossRef Willemsen M, De Doncker P, Willems J, et al. Posttreatment itraconazole levels in the nail. J Am Acad Dermatol 1992; 26: 731–5.PubMedCrossRef
40.
Zurück zum Zitat De Doncker P, Decroix J, Pierard GE, et al. Antifungal pulse therapy for onychomycosis. Arch Dermatol 1996; 132: 34–41.PubMedCrossRef De Doncker P, Decroix J, Pierard GE, et al. Antifungal pulse therapy for onychomycosis. Arch Dermatol 1996; 132: 34–41.PubMedCrossRef
41.
Zurück zum Zitat Faergemann J, Zehender H, Boukhabza A, et al. A double-blind comparison of levels of terbinafine and itraconazole in plasma, skin, sebum, hair and nails during and after oral medication [letter]. Acta Derm Venereol 1997; 77: 74–6.PubMed Faergemann J, Zehender H, Boukhabza A, et al. A double-blind comparison of levels of terbinafine and itraconazole in plasma, skin, sebum, hair and nails during and after oral medication [letter]. Acta Derm Venereol 1997; 77: 74–6.PubMed
42.
Zurück zum Zitat Faergemann J, Laufen H. Levels of fluconazole in normal and diseased nails during and after treatment of onychomycoses in toe-nails with fluconazole 150mg once weekly. Acta Derm Venereol 1996; 76: 219–21.PubMed Faergemann J, Laufen H. Levels of fluconazole in normal and diseased nails during and after treatment of onychomycoses in toe-nails with fluconazole 150mg once weekly. Acta Derm Venereol 1996; 76: 219–21.PubMed
43.
Zurück zum Zitat Laufen H, Zimmermann T, Yeates RA, et al. The uptake of fluconazole in finger and toe nails. Int J Clin Pharmacol Ther 1999; 37: 352–60.PubMed Laufen H, Zimmermann T, Yeates RA, et al. The uptake of fluconazole in finger and toe nails. Int J Clin Pharmacol Ther 1999; 37: 352–60.PubMed
44.
Zurück zum Zitat Dykes PJ, Thomas R, Finlay AY. Determination of terbinafine in nail samples during systemic treatment for onychomycoses. Br J Dermatol 1990; 123: 481–6.PubMedCrossRef Dykes PJ, Thomas R, Finlay AY. Determination of terbinafine in nail samples during systemic treatment for onychomycoses. Br J Dermatol 1990; 123: 481–6.PubMedCrossRef
45.
Zurück zum Zitat Finlay AY, Lever L, Thomas R, et al. Nail matrix kinetics of oral terbinafine in onychomycosis and normal nails. J Dermatol Treat 1990; 1 Suppl. 2: 51–3.CrossRef Finlay AY, Lever L, Thomas R, et al. Nail matrix kinetics of oral terbinafine in onychomycosis and normal nails. J Dermatol Treat 1990; 1 Suppl. 2: 51–3.CrossRef
46.
Zurück zum Zitat Faergemann J, Zehender H, Denouël J, et al. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250mg terbinafine orally once per day for four weeks. Acta Derm Venereol 1993; 73: 305–9.PubMed Faergemann J, Zehender H, Denouël J, et al. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250mg terbinafine orally once per day for four weeks. Acta Derm Venereol 1993; 73: 305–9.PubMed
47.
Zurück zum Zitat Faergemann J, Zehender H, Millerioux L. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stra tum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days. Clin Exp Dermatol 1994; 19: 121–6.PubMedCrossRef Faergemann J, Zehender H, Millerioux L. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stra tum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days. Clin Exp Dermatol 1994; 19: 121–6.PubMedCrossRef
48.
Zurück zum Zitat Matsumoto T, Tanuma H, Kaneko S, et al. Clinical and pharma-cokinetic investigations of oral terbinafine in patients with tinea unguium. Mycoses 1995; 38: 135–44.PubMedCrossRef Matsumoto T, Tanuma H, Kaneko S, et al. Clinical and pharma-cokinetic investigations of oral terbinafine in patients with tinea unguium. Mycoses 1995; 38: 135–44.PubMedCrossRef
49.
Zurück zum Zitat Faergemann J, Zehender H, Jones T, et al. Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat. Acta Demi Venereol 1990; 71: 322–6. Faergemann J, Zehender H, Jones T, et al. Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat. Acta Demi Venereol 1990; 71: 322–6.
50.
Zurück zum Zitat Suzuki S, Inoue T, Hori H, et al. Analysis of methamphetamine in hair, nail, sweat and saliva by mass fragmentography. J Anal Toxicol 1989; 13: 176–8.PubMed Suzuki S, Inoue T, Hori H, et al. Analysis of methamphetamine in hair, nail, sweat and saliva by mass fragmentography. J Anal Toxicol 1989; 13: 176–8.PubMed
51.
Zurück zum Zitat Cirimele V, Kintz P, Margin P. Detection of amphetamines in fingernails: an alternative to hair analysis. Arch Toxicol 1995; 70: 68–9.PubMedCrossRef Cirimele V, Kintz P, Margin P. Detection of amphetamines in fingernails: an alternative to hair analysis. Arch Toxicol 1995; 70: 68–9.PubMedCrossRef
52.
Zurück zum Zitat Lemos NP, Anderson RA, Robertson JR. Nail analysis for drugs of abuse [abstract]. Proceedings of the Joint SOFT/TIAFT International Meeting; 1998 Oct 5–9; Albuquerque (NM). Lemos NP, Anderson RA, Robertson JR. Nail analysis for drugs of abuse [abstract]. Proceedings of the Joint SOFT/TIAFT International Meeting; 1998 Oct 5–9; Albuquerque (NM).
53.
Zurück zum Zitat Engelhart DA, Lavins ES, Sutheimer CA. Detection of drugs of abuse in nails. J Anal Toxicol 1998; 22: 314–8.PubMed Engelhart DA, Lavins ES, Sutheimer CA. Detection of drugs of abuse in nails. J Anal Toxicol 1998; 22: 314–8.PubMed
54.
Zurück zum Zitat Engelhart DA, Jenkins AJ. Identification of cocaine, opiates and their metabolites in nails from postmortem cases [abstract]. Proceedings of the Joint SOFT/TIAFT International Meeting; 1998 Oct 5–9; Albuquerque (NM). Engelhart DA, Jenkins AJ. Identification of cocaine, opiates and their metabolites in nails from postmortem cases [abstract]. Proceedings of the Joint SOFT/TIAFT International Meeting; 1998 Oct 5–9; Albuquerque (NM).
55.
Zurück zum Zitat Garside D, Ropero-Miller JD, Goldberger BA, et al. Identification of cocaine analytes in fingernail and toenail specimens. J Forensic Sci 1998; 43: 974–9.PubMed Garside D, Ropero-Miller JD, Goldberger BA, et al. Identification of cocaine analytes in fingernail and toenail specimens. J Forensic Sci 1998; 43: 974–9.PubMed
56.
Zurück zum Zitat Skopp G, Pötsch L. A case report on drug screening of nail clippings to detect prenatal drug exposure. Ther Drug Monit 1997; 19: 386–9.PubMedCrossRef Skopp G, Pötsch L. A case report on drug screening of nail clippings to detect prenatal drug exposure. Ther Drug Monit 1997; 19: 386–9.PubMedCrossRef
57.
Zurück zum Zitat Tagliaro F, De Battisti Z, Lubli G, et al. Integrated use of hair analysis to investigate the physical fitness to obtain the driving licence: a case-work study. Forensic Sci Int 1997; 84: 129–35.PubMedCrossRef Tagliaro F, De Battisti Z, Lubli G, et al. Integrated use of hair analysis to investigate the physical fitness to obtain the driving licence: a case-work study. Forensic Sci Int 1997; 84: 129–35.PubMedCrossRef
58.
Zurück zum Zitat Miller M, Martz R, Donnelly B. Drugs in keratin samples from hair, fingernails and toenails [abstract]. Second International Meeting on Clinical and Forensic Aspect of Hair Analysis; 1994 Jun 6–8; Genoa, Italy. Miller M, Martz R, Donnelly B. Drugs in keratin samples from hair, fingernails and toenails [abstract]. Second International Meeting on Clinical and Forensic Aspect of Hair Analysis; 1994 Jun 6–8; Genoa, Italy.
59.
Zurück zum Zitat Ropero-Miller JD, Goldberger BA, Oyler JM, et al. Drug testing with alternative matrices: cocaine disposition in hair and fingernails [abstract]. Annual Meeting of American Academy of Forensic Sciences. 1999 Feb 15–20; Orlando (FL). Ropero-Miller JD, Goldberger BA, Oyler JM, et al. Drug testing with alternative matrices: cocaine disposition in hair and fingernails [abstract]. Annual Meeting of American Academy of Forensic Sciences. 1999 Feb 15–20; Orlando (FL).
60.
Zurück zum Zitat Fox CH. Cocaine use in pregnancy. J Am Board Fam Pract 1994; 7: 225–8.PubMed Fox CH. Cocaine use in pregnancy. J Am Board Fam Pract 1994; 7: 225–8.PubMed
Metadaten
Titel
Drugs in Nails
Physiology, Pharmacokinetics and Forensic Toxicology
verfasst von
Alessandro Palmeri
Simona Pichini
Roberta Pacifici
Dr Piergiorgio Zuccaro
Annunziata Lopez
Publikationsdatum
01.02.2000
Verlag
Springer International Publishing
Erschienen in
Clinical Pharmacokinetics / Ausgabe 2/2000
Print ISSN: 0312-5963
Elektronische ISSN: 1179-1926
DOI
https://doi.org/10.2165/00003088-200038020-00001